Estimated PK parameters
Compound . | Comp . | Cl, mL/h per kg . | V1, mL/kg . | V2, mL/kg . | t1/2 alfa, h . | t1/2 beta, h . | MRT, h . |
---|---|---|---|---|---|---|---|
FVII | 2 | 609 | 304 | 336 | 0.19 | 1.4 | 1.0 |
FVII_X | 2 | 176 | 244 | 966 | 0.10 | 6.3 | 6.6 |
FX | 2 | 25 | 105 | 102 | 0.08 | 8.6 | 6.3 |
FXai | 1 | 354 | 216 | 0.42 | 0.6 | ||
FVII_XHC | 2 | 82 | 194 | 305 | 0.12 | 5.4 | 5.5 |
FVII_X1-34 | 2 | 249 | 228 | 490 | 0.15 | 3.6 | 2.6 |
FVII_X30-52 | 2 | 295 | 246 | 1080 | 0.13 | 4.2 | 4.4 |
FVII_XNNAA | 2 | 115 | 173 | 259 | 0.16 | 3.8 | 3.4 |
FVII_XTTAA | 2 | 146 | 200 | 747 | 0.11 | 5.7 | 6.3 |
Compound . | Comp . | Cl, mL/h per kg . | V1, mL/kg . | V2, mL/kg . | t1/2 alfa, h . | t1/2 beta, h . | MRT, h . |
---|---|---|---|---|---|---|---|
FVII | 2 | 609 | 304 | 336 | 0.19 | 1.4 | 1.0 |
FVII_X | 2 | 176 | 244 | 966 | 0.10 | 6.3 | 6.6 |
FX | 2 | 25 | 105 | 102 | 0.08 | 8.6 | 6.3 |
FXai | 1 | 354 | 216 | 0.42 | 0.6 | ||
FVII_XHC | 2 | 82 | 194 | 305 | 0.12 | 5.4 | 5.5 |
FVII_X1-34 | 2 | 249 | 228 | 490 | 0.15 | 3.6 | 2.6 |
FVII_X30-52 | 2 | 295 | 246 | 1080 | 0.13 | 4.2 | 4.4 |
FVII_XNNAA | 2 | 115 | 173 | 259 | 0.16 | 3.8 | 3.4 |
FVII_XTTAA | 2 | 146 | 200 | 747 | 0.11 | 5.7 | 6.3 |
NMRI mice were dosed 1 mg/kg of the listed compounds intravenously.
Comp indicates the estimated number of compartments in the pharmacokinetic model; Cl, clearance; V1, central compartment; V2, peripheral compartment; t1/2alpha, distribution half-life; t1/2beta, terminal half-life; and MRT, mean residence time.